Prescient Therapeutics Limited (AU:PTX) has released an update.
Prescient Therapeutics Limited has announced the cessation of 415,000 options due to their expiry on June 1, 2024, without being exercised or converted. This notification is provided as a formal disclosure to the market and represents a new announcement for the investors and stakeholders of the company.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.